CureVac appoints Thaminda Ramanayake as CBO

CureVac announced that Thaminda Ramanayake has been appointed to the role of Chief Business Officer, effective June 1, 2024. He joins CureVac from Affini-T Therapeutics, where he served as Chief Business Officer and was responsible for creating the company’s business development organization.